Abstract

You have accessJournal of UrologyEducation Research III (MP20)1 Sep 2021MP20-13 FROM ABSTRACT TO MANUSCRIPT: EVALUATING UROLOGIC ONCOLOGY PUBLICATION RATES FROM AUA ANNUAL MEETINGS (2012-2019) Megan Prunty, Stephen Rhodes, Noah Yaffe, Sarah Markt, Lauren Snodgrass, Clint Cary, Ronald S. Boris, Laura Bukavina, and Adam C. Calaway Megan PruntyMegan Prunty More articles by this author , Stephen RhodesStephen Rhodes More articles by this author , Noah YaffeNoah Yaffe More articles by this author , Sarah MarktSarah Markt More articles by this author , Lauren SnodgrassLauren Snodgrass More articles by this author , Clint CaryClint Cary More articles by this author , Ronald S. BorisRonald S. Boris More articles by this author , Laura BukavinaLaura Bukavina More articles by this author , and Adam C. CalawayAdam C. Calaway More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002005.13AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: We analyzed the differences in organ system, publication rate, time-to-publication, and impact factor of manuscripts from all oncology-related abstracts from the American Urological Association (AUA) Annual Meeting between 2012 and 2019. METHODS: We used the titles of 6,347 AUA Abstracts to query PubMed for associated manuscripts. To infer publication status from title similarity, an independent rater sampled 300 records to identify whether each Pubmed record was related to an AUA abstract. These ratings were used to fit a logistic regression predicting publication status of AUA abstracts from our title similarity measure (94.5% accurate). Logistic regression models assessed publication rate by author gender, type of presentation, and research category. F-tests were used to analyze impact factor and time-to-publication. RESULTS: 18% of abstracts resulted in publication. In comparing organ of interest, prostate cancer manuscripts resulted in significantly higher impact factor (IF) publications than both bladder (p=0.044) and kidney (p=0.005). Penile cancer had significantly fewer citations per year relative to bladder (p=0.002), kidney (p=0.002), and prostate (p=0.003). The other categories did not significantly differ from each other (ps>0.09). In comparing poster vs. podium AUA presentations, if published, podiums resulted in higher IF journals publications (p=0.0006), although no difference in citations were seen (F (1,821)=0.45, p=0.5). There was no significant difference in publication rate (χ2(1)=0.39, p=0.53) or time-to-publication (F(1,847)=0.32, p=0.57) between poster or podium. There has been no significant increase in AUA abstracts in oncology by females between 2012 and 2019 (χ2(1)=2.43, p=0.12). Author gender did not influence publication status (χ2(3)=1.48, p=0.69) or impact factor of published works (F(3,794)=0.62, p=0.6). CONCLUSIONS: In urologic oncology, only 13.8% of AUA Abstracts are subsequently published as manuscripts. Efforts to move abstracts into publication are needed to mitigate academic waste and encourage productivity. Prostate cancer podiums are published in higher IF journals. However, this does not translate to more citations per year for prostate cancer manuscripts. Source of Funding: n/a © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e341-e342 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Megan Prunty More articles by this author Stephen Rhodes More articles by this author Noah Yaffe More articles by this author Sarah Markt More articles by this author Lauren Snodgrass More articles by this author Clint Cary More articles by this author Ronald S. Boris More articles by this author Laura Bukavina More articles by this author Adam C. Calaway More articles by this author Expand All Advertisement Loading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call